US Drug Recall Register
Class II · Moderate risk Terminated Initiated Nov 7, 2014 (12 years ago)

Testosterone Cyp 200 mg/mL Sesame Inj.

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

What was recalled

Testosterone Cyp 200 mg/mL Sesame Inj., 4Ml Syringes, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC 88888-7906-71

Recalling firm
Perry Drug Inc.
NDC code
88888-7906-71
Origin
KS, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0264-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Testosterone recalls

See all
Class II · Moderate risk Ongoing

Testosterone 100mg Anastrozole 4mg

Reason Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0331-2026
Class II · Moderate risk Ongoing

Testosterone 87.5mg

Reason Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0330-2026
Class II · Moderate risk Ongoing

Testosterone 200mg

Reason Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0329-2026
Class II · Moderate risk Ongoing

Testosterone 100mg

Reason Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0328-2026
Class II · Moderate risk Ongoing

Testosterone 75mg

Reason Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0327-2026